Österreich » News & Media » Pressemitteilungen

Details

19.05.11

STALLERGENES OBTAINS A MARKETING AUTHORIZATION FOR ORALAIR® IN AUSTRALIA

 

Antony (France), 18 May 2011 - Stallergenes S.A. has announced that the Australian health
authority, the Therapeutic Goods Administration (TGA), has approved the grass pollen sublingual
immunotherapy tablet Oralair® in adult and pediatric indications.